A Comprehensive Review on Copemyl(®)

Economic sustainability is of paramount importance in the rapidly evolving therapeutic scenario of multiple sclerosis (MS). Glatiramoids are a class of drugs whose forefather, glatiramer acetate, has been used as a disease modifying drug (DMD) in patients with MS for over 20 years. Its patent expire...

Descripción completa

Detalles Bibliográficos
Autores principales: Annovazzi, Pietro, Bertolotto, Antonio, Brescia Morra, Vincenzo, Gasperini, Claudio, Montanari, Enrico, Navarra, Pierluigi, Patti, Francesco, Sormani, Maria Pia, Ghezzi, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700901/
https://www.ncbi.nlm.nih.gov/pubmed/28762192
http://dx.doi.org/10.1007/s40120-017-0079-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700901/
https://www.ncbi.nlm.nih.gov/pubmed/28762192
http://dx.doi.org/10.1007/s40120-017-0079-3

Ejemplares similares